Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.

Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

Mom of three Anna Usher told Newsweek that she wasn't sure how the pregnancy-test idea would play out at first.

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...

Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...

Scientists used DNA testing on 1,200-year-old feces to detect E. coli, pinworms, and Giardia in ancient Mexico, and found ...

A woman turned to Reddit after learning her close friend kept quiet about a contagious illness that left her severely ill and ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute ...

Victoria is ramping up its biosecurity defences against H5N1 bird flu, with new federal support to boost emergency preparedness and rapid response ...

Ancient DNA from Napoleon’s soldiers reveals enteric and relapsing fevers - not typhus - as key killers during the army’s ...